Tuberculosis, the world's deadliest infectious disease, is estimated to infect around 10 million people each year, and kills ...

Recently approved medications for resistant hypertension, uncomplicated UTIs and menopausal hot flashes show potential as ...

Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 ...

Christine Webber column on the risks of drinking too much and what kind of relationship we should have with alcohol.

A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...

Discover why Mirum Pharmaceuticals is a growth opportunity with billion-dollar pipeline potentials, near-term catalysts, and ...

Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial published in The New England Journal of Medicine.

Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...

Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.

Metastatic castration-resistant prostate cancer (mCRPC) is diagnosed by blood tests, imaging scans, and biopsies. Find out ...

Replimune Group, Inc.'s RP1 + OPDIVO for advanced melanoma gains FDA Priority Review. PDUFA date: July 22, 2025. Read more on ...

Removing EPO signaling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.